.svg)
Latest Business News
Stocks Making Headlines in Friday Midday Trading
Freyr Battery
Freyr Battery saw an 18% surge in its stock price after Morgan Stanley upgraded the battery maker to overweight from equal weight. Analyst Adam Jonas set a price target of $13, indicating a potential upside of over 70% for the stock.
Wells Fargo, JPMorgan Chase, and Bank of America
All three banks experienced an uptick in their stock prices after passing a key annual stress test conducted by the Federal Reserve. This test demonstrated that the banks could effectively weather a recession scenario. Wells Fargo gained 3.4%, while both JPMorgan and Bank of America saw increases of over 2%.
Tenaris
Pipe manufacturer Tenaris rose by 2.4% following Jefferies' initiation of coverage for the stock with a buy rating. The firm cited a compelling risk/reward ratio and predicted that shares could potentially rise by more than 45%.
Micron Technology
The chip stock saw a decline of 3.4% after reporting revenue of $3.75 billion, surpassing analyst expectations. Micron also stated that it believes the memory chip industry has passed its revenue trough. However, uncertainties in China regarding restrictions on Micron's products continue to impact the company.
Occidental Petroleum
Shares of Occidental Petroleum increased by nearly 1% after Warren Buffett's Berkshire Hathaway purchased an additional 2.1 million Occidental shares, raising its stake in the company to 25.1%. This move by Berkshire Hathaway reflects Buffett's ongoing interest in the energy producer.
Joby Aviation
Joby Aviation experienced a 14% surge in its stock price following a $100 million investment from SK Telecom. This investment comes after Joby Aviation received a permit to begin flight testing its first electric vertical takeoff and landing aircraft, which caused shares to surge by 40% on Wednesday.
Overstock.com
The online retailer saw a 16% increase in its stock price after closing a deal to purchase the Bed Bath & Beyond brand out of bankruptcy. This acquisition represents a strategic move for Overstock.com to expand its presence in the home goods market.
Sigilon Therapeutics
Sigilon Therapeutics experienced a significant surge of over 500% in its stock price after pharmaceutical company Eli Lilly announced plans to acquire Sigilon. The proposed acquisition could lead to a purchase price of up to $126.56 per share.
BioXcel Therapeutics
BioXcel Therapeutics saw its stock price plummet by 65% after reporting an issue with the timeliness of correspondence between a principal investigator with the U.S. Food and Drug Administration. This issue relates to a phase 3 trial for an Alzheimer's treatment being conducted by the company.
Conclusion: Potential Impact on New Business
The recent stock market movements demonstrate the potential impact on new businesses, both positive and negative, based on various factors.
For new businesses operating in the battery and clean energy sector, the surge in Freyr Battery's stock price highlights the potential for growth and investor confidence. A positive rating and price target from a renowned analyst firm like Morgan Stanley can significantly boost a company's stock value, attracting more investors and providing the necessary capital for expansion and innovation.
On the other hand, uncertainties in certain industries can have adverse effects. The decline in Micron Technology's stock price, despite surpassing revenue expectations, indicates that external factors such as international trade restrictions can overshadow positive financial performance. This suggests that new businesses operating in global markets should carefully consider geopolitical risks and be prepared to navigate through potential hurdles.
The acquisition announcements involving Sigilon Therapeutics and Overstock.com show how favorable market news can have a dramatic impact on a company's stock price. These developments can be particularly relevant for new businesses as they showcase the potential for strategic partnerships, market expansion, and investor confidence.
However, the significant stock drop experienced by BioXcel Therapeutics due to an issue with regulatory correspondence serves as a reminder of the potential risks faced by healthcare companies reliant on regulatory approvals. New businesses in the pharmaceutical industry should pay close attention to their regulatory compliance and maintain open communication with regulatory bodies to avoid similar setbacks.
In conclusion, the stock market movements analyzed here highlight the importance of various factors, including analyst ratings, industry trends, regulatory compliance, and strategic partnerships, in influencing the performance of new businesses. While positive developments can yield significant gains, potential risks and external uncertainties should also be actively managed to mitigate adverse impacts on stock value and business operations.
Article First Published at: https://www.cnbc.com/2023/06/29/stocks-moving-big-midday-oxy-wfc-mu-joby.html
